Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Tolerogenic dendritic cell vaccines to treat autoimmune diseases: Can the unattainable dream turn into reality?
Prevalence of extracranial venous narrowing on catheter venography in people with multiple sclerosis, their siblings, and unrelated healthy controls: a blinded, case-control study.
Protective and Detrimental Roles for Regulatory T Cells in a Viral Model for Multiple Sclerosis.
Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis.
CONTINUUM Multiple Sclerosis: Teaching Us About More Than MS and Its ABCs.
Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica.
2nd International Symposium on Gait and Balance in Multiple Sclerosis: interventions for gait and balance in MS.
Evolution of Quality of Life in Renal Transplant Recipients and Patients With Multiple Sclerosis: A Follow-up Study.
Il-17 And Glutamte Excitotoxicity In The Pathogenesis Of Multiple Sclerosis.
Determining the Presence of Reliable Change over Time in Multiple Sclerosis: Evidence from the PASAT, Adjusting-PSAT, and Stroop Test
Comparison of two commercial ELISA systems for evaluating anti-EBNA1 IgG titers.
The importance of CCR4 and CCR6 in experimental autoimmune encephalomyelitis.
Characterization of In Vitro Expanded Bone Marrow-Derived Mesenchymal Stem Cells Isolated from Experimental Autoimmune Encephalomyelitis Mice.
Impact on health-related quality of life in multiple sclerosis patients due to a managed care program in Colombia.
Dual Targeting of the Chemokine Receptors CXCR4 and ACKR3 with Novel Engineered Chemokines.
Paroxetine-Related Adult-Onset Tic Disorder: A Presentation of Primary Progressive Multiple Sclerosis.
The ribosomal S6 kinase inhibitor BI-D1870 ameliorated experimental autoimmune encephalomyelitis in mice.
Home functioning profiles in people with multiple sclerosis and their relation to disease characteristics and psychosocial functioning.
The Potential of Metabolic Imaging.
Bilateral Surgical Reconstruction for Internal Jugular Veins Disease in Patients With Chronic Cerebrospinal Venous Insufficiency and associated Multiple Sclerosis.
Neuroinflammation. Contemporary anti-inflammatory treatment approaches.
Sox5 and c-Maf cooperatively induce Th17 cell differentiation via RORγt induction as downstream targets of Stat3.
The role of transcriptional control in multiple system atrophy.
Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy?
The role of cerebellar abnormalities in neuromyelitis optica - a comparison with multiple sclerosis and healthy controls.
Pages
« first
‹ previous
…
374
375
376
377
378
379
380
381
382
…
next ›
last »